Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (501-510 of 715) with videos related to

Pageof 72
Sort By:
Lancet (London, England)|November 7, 1981
Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activatorW Weimar, J Stibbe, A J van Seyen, et al.
The Journal of Biological Chemistry|November 25, 1987
Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3M J Heeb, F España, M Geiger, et al.
Thrombosis and Haemostasis|November 1, 1996
Functional significance of NH2- and COOH-terminal regions of staphylokinase in plasminogen activationA Gase, M Hartmann, K H Gührs, et al.
Science (New York, N.Y.)|June 10, 1983
Clot-selective coronary thrombolysis with tissue-type plasminogen activatorS R Bergmann, K A Fox, M M Ter-Pogossian, et al.
Thrombosis and Haemostasis|March 11, 1998
Nucleotide structure and characterization of the murine gene encoding anticoagulant protein CL R Jalbert, E D Rosen, A Lissens, et al.
Thrombosis Research|March 15, 1984
Effects of DDAVP and venous occlusion on the release of tissue-type plasminogen activator and von Willebrand factor in patients with panhypopituitarismI Juhan-Vague, B Conte-Devolx, M F Aillaud, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivationH R Lijnen, B Van Hoef, I Vanlinthout, et al.
Thrombosis and Haemostasis|April 2, 1992
Biochemical, thrombolytic and pharmacokinetic properties of rt-PA P47G, K49N, a substitution variant of human tissue-type plasminogen activatorL Nelles, X K Li, I Vanlinthout, et al.
The Journal of Cell Biology|February 14, 1998
Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in miceP Carmeliet, L Moons, M Dewerchin, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Recombinant human microplasmin: production and potential therapeutic propertiesN Nagai, E Demarsin, B Van Hoef, et al.
Pageof 72

Showing results (501-510 of 715) with videos related to

Sort By:
Pageof 72
Lancet (London, England)|November 7, 1981
Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activatorW Weimar, J Stibbe, A J van Seyen, et al.
The Journal of Biological Chemistry|November 25, 1987
Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3M J Heeb, F España, M Geiger, et al.
Thrombosis and Haemostasis|November 1, 1996
Functional significance of NH2- and COOH-terminal regions of staphylokinase in plasminogen activationA Gase, M Hartmann, K H Gührs, et al.
Science (New York, N.Y.)|June 10, 1983
Clot-selective coronary thrombolysis with tissue-type plasminogen activatorS R Bergmann, K A Fox, M M Ter-Pogossian, et al.
Thrombosis and Haemostasis|March 11, 1998
Nucleotide structure and characterization of the murine gene encoding anticoagulant protein CL R Jalbert, E D Rosen, A Lissens, et al.
Thrombosis Research|March 15, 1984
Effects of DDAVP and venous occlusion on the release of tissue-type plasminogen activator and von Willebrand factor in patients with panhypopituitarismI Juhan-Vague, B Conte-Devolx, M F Aillaud, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivationH R Lijnen, B Van Hoef, I Vanlinthout, et al.
Thrombosis and Haemostasis|April 2, 1992
Biochemical, thrombolytic and pharmacokinetic properties of rt-PA P47G, K49N, a substitution variant of human tissue-type plasminogen activatorL Nelles, X K Li, I Vanlinthout, et al.
The Journal of Cell Biology|February 14, 1998
Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in miceP Carmeliet, L Moons, M Dewerchin, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Recombinant human microplasmin: production and potential therapeutic propertiesN Nagai, E Demarsin, B Van Hoef, et al.
Pageof 72